A Nanostrategy for Efficient Imaging‐Guided Antitumor Therapy through a Stimuli‐Responsive Branched Polymeric ProdrugHao Cai, Kui Luo, Xinghang Dai et al.|Advanced Science|2020Cited by 205
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinomaJunhui Hu, Lily Wu, Ping Tan et al.|Signal Transduction and Targeted Therapy|2023Cited by 76
ADP-dependent glucokinase controls metabolic fitness in prostate cancer progressionHang Xu, Jianzhong Ai, Yifan Li et al.|Military Medical Research|2023Cited by 17
CD93 orchestrates the tumor microenvironment and predicts the molecular subtype and therapy response of bladder cancerXiaonan Zheng, Qiang Wei, Tianhai Lin et al.|Computers in Biology and Medicine|2022Cited by 11
A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).Feng Wen, Yali Shen, Tianhai Lin et al.|Journal of Clinical Oncology|2025Cited by 3